Cargando…
Placebo-controlled trial of oral amantadine and zolpidem efficacy on the outcome of patients with acute severe traumatic brain injury and diffuse axonal injury
BACKGROUND: A constituent of diffuse axonal injury (DAI) is supposed to be present in about 1/3 of all severe traumatic brain injury (TBI) as specified by pathologic documents. Diffuse axonal injury is categorized by extensive injury to axons in the brain. A rise in the incidences of TBI, and the li...
Autores principales: | Shafiee, Sajad, Ehteshami, Saeed, Moosazadeh, Mahmood, Aghapour, Saeed, Haddadi, Kaveh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797827/ https://www.ncbi.nlm.nih.gov/pubmed/35178216 http://dx.doi.org/10.22088/cjim.13.1.113 |
Ejemplares similares
-
The Effect of Oral Administration of Amantadine on Neurological
Outcome of Patients With Diffuse Axonal Injury in ICU
por: Abbasivash, Rahman, et al.
Publicado: (2019) -
Effect of Zolpidem in the Aftermath of Traumatic Brain Injury: An MEG Study
por: Sripad, Praveen, et al.
Publicado: (2020) -
Amantadine Effect on Perceptions of Irritability after Traumatic Brain Injury: Results of the Amantadine Irritability Multisite Study
por: Hammond, Flora M., et al.
Publicado: (2015) -
Effects of Minocycline on Neurological Outcomes In Patients With Acute Traumatic Brain Injury: A Pilot Study
por: Koulaeinejad, Neda, et al.
Publicado: (2019) -
Progress of Research on Diffuse Axonal Injury after Traumatic Brain Injury
por: Ma, Junwei, et al.
Publicado: (2016)